Pirfenidone Inhibits Obliterative Airway Disease in Mouse Tracheal Allografts
- 16 May 2005
- journal article
- research article
- Published by Elsevier in The Journal of Heart and Lung Transplantation
- Vol. 24 (10) , 1577-1585
- https://doi.org/10.1016/j.healun.2004.11.002
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Recipient intramuscular administration of naked plasmid TGF-β1 attenuates lung graft reperfusion injuryThe Journal of Heart and Lung Transplantation, 2003
- Graft protective effects of heme oxygenase 1 in mouse tracheal transplant-related obliterative bronchiolitis1Transplantation, 2003
- The registry of the international society for heart and lung transplantation: twentieth official adult lung and heart–lung transplant report—2003Published by Elsevier ,2003
- Bronchiolitis Obliterans after Human Lung TransplantationAmerican Journal of Respiratory and Critical Care Medicine, 2002
- Growth Factor Upregulation during Obliterative Bronchiolitis in the Mouse ModelAmerican Journal of Respiratory and Critical Care Medicine, 2002
- Attenuation of cardiac fibrosis by pirfenidone and amiloride in DOCA‐salt hypertensive ratsBritish Journal of Pharmacology, 2002
- Risk factors for bronchiolitis obliterans: a systematic review of recent publicationsThe Journal of Heart and Lung Transplantation, 2002
- The heterotopic tracheal allograft as an animal model of obliterative bronchiolitisRespiratory Research, 2001
- Treatment of Idiopathic Pulmonary Fibrosis with a New Antifibrotic Agent, PirfenidoneAmerican Journal of Respiratory and Critical Care Medicine, 1999
- Pirfenidone: a novel antifibrotic agent with implications for the treatment of obliterative bronchiolitisTransplantation Proceedings, 1998